The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 19,601–19,700 of 31,469
Kawabeta, K., Hase-Tamaru, S., Yuasa, M., Suruga, K., Sugano, M., & Koba, K. (2019) · Journal of Oleo Science · doi:10.5650/jos.ess18232 · Cited by 12
Eichner, N. Z. M., Gilbertson, N. M., Musante, L., Salvia, S. L., WELTMAN, A. L., Erdbrügger, U., & Malin, S. K. (2019) · Nutrients · doi:10.3390/nu11030580 · Cited by 12
Does sex hormone-binding globulin cause insulin resistance during pubertal growth?
Le, S., Xu, L., Schumann, M., Wu, N., Törmäkangas, T., Alén, M., Cheng, S., & Wiklund, P. (2019) · Endocrine Connections · doi:10.1530/ec-19-0044 · Cited by 12
Orlando, A., Viazzi, F. C., Giussani, M., Nava, E., Cazzaniga, E., Bonino, B., Palestini, P., Parati, G., & Genovesi, S. (2019) · Hypertension Research · doi:10.1038/s41440-019-0253-3 · Cited by 12
Serum retinol-binding protein 4 levels in polycystic ovary syndrome
Lingaiah, S., Morin-Papunen, L. C., Piltonen, T., Poromaa, I. S., Stener‐Victorin, E., & Tapanainen, J. S. (2019) · Endocrine Connections · doi:10.1530/ec-19-0116 · Cited by 12
Scalzo, R. L., Rafferty, D., Schauer, I. E., Huebschmann, A. G., Cree‐Green, M., Reusch, J. E. B., & Regensteiner, J. G. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.002 · Cited by 12
Tao, T., Wang, Y., Xu, B., Mao, X., Sun, Y. W., & Liu, W. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110450 · Cited by 12
Depression Severity as a Risk Factor of Sarcopenic Obesity in Morbidly Obese Patients
Venant, V., Pouget, M., Lahaye, C., Gentes, E., Pereira, B., Lambert, C., Debarges, J., Domingues-Faria, C., Palmier-Forestier, C., Farigon, N., et al. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1218-6 · Cited by 12
Chawala, S., Pund, A., Vibishan, B., Kulkarni, S., Diwekar-Joshi, M., & Watve, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204755 · Cited by 13
Lundström, E., Ljungberg, J., Andersson, J., Manell, H., Strand, R., Forslund, A. H., Bergsten, P., Weghuber, D., Mörwald, K., Zsoldos, F., et al. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12531 · Cited by 12
Yu, H. M., Kim, S. J., Chun, S. W., Park, K. Y., Lim, D. M., Lee, J. M., Hong, J. H., & Park, K. S. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107796 · Cited by 13
Isobe, Y., Nakatsumi, Y., Sugiyama, Y., et al. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3005-19 · Cited by 12
Dikker, O., Dağ, N. Ç., Şahin, M., Türkkan, E., & Dağ, H. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154802 · Cited by 12
Lee, S. Y., Burns, S. F., NG, K. K. C., Stensel, D. J., Zhong, L., Tan, F. H. Y., Chia, K. L., Fam, K. D., Yap, M. M. C., Yeo, K. P., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002150 · Cited by 14
Guaraldi, G., Franconi, I., Milić, J., Besutti, G., Pintassilgo, I., Scaglioni, R., Ligabue, G., Riva, N., Raimondi, A., Menozzi, M., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz435 · Cited by 12
Demir, İ., Akan, O. Y., Güler, A., Bozkaya, G., Aslanıpour, B., & Çalan, M. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.10.003 · Cited by 13
Stavnsbo, M., Aadland, E., Anderssen, S. A., Chinapaw, M. J. M., Steene‐Johannessen, J., Andersen, L. B., & Resaland, G. K. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105868 · Cited by 14
Iwata, M., Kamura, Y., Honoki, H., Kobayashi, K., Ishiki, M., Yagi, K., Fukushima, Y., Takano, A., Kato, H., Murakami, S., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13176 · Cited by 14
El-Kafoury, B. M. A., Ahmed, M. A., Hammouda, G. A., ElKady, A. H., & Lasheen, N. N. (2019) · Physiological Reports · doi:10.14814/phy2.14282 · Cited by 12
Impact of Recreational Sports Activities on Metabolic Syndrome Components in Adolescents
de Faria, F. R., Howe, C. A., de Faria, R. C., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010143 · Cited by 12
Xie, X., Peng, Z., Li, H., Li, D., Tu, Y., Bai, Y., Xingfu, H., Lai, W., Zhan, Q., Zeng, Q., et al. (2020) · BioMed Research International · doi:10.1155/2020/5240153 · Cited by 12
Morimoto, A., Kadoya, M., Kakutani‐Hatayama, M., Kosaka‐Hamamoto, K., Miyoshi, A., Shoji, T., Goda, A., Asakura, M., & Koyama, H. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100025 · Cited by 12
Mujaj, B., Bos, D., Kavousi, M., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0620 · Cited by 12
Бiловол, О. М., Knyazkova, І. І., Al-Travneh, O. V., Bogun, M. V., & Berezin, A. Е. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.01.011 · Cited by 14
Weight Change and Its Association with Cardiometabolic Risk Markers in Overweight and Obese Women
Zamri, L. A., Appannah, G., Zahari-Sham, S. Y., Mansor, F., Ambak, R., Nor, N. S. M., & Aris, T. (2020) · Journal of Obesity · doi:10.1155/2020/3198326 · Cited by 12
Nabil, M., Demellawy, M. E., Mahmoud, M. F., & Mahmoud, A. A. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173136 · Cited by 12
Shaat, N., Katsarou, A., Shahida, B., Prasad, R. B., Kristensen, K. H., & Planck, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232297 · Cited by 12
Davids, S. F. G., Matsha, T. E., Peer, N., Erasmus, R. T., & Kengne, A. P. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3781214 · Cited by 12
Gurka, M. J., Mack, J. A., Chi, X., & DeBoer, M. D. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15131 · Cited by 12
Ashihara, N., Watanabe, T., Kako, S., Kuraishi, Y., Ozawa, M., Shigefuji, S., Kanai, K., Usami, Y., Yamada, A., Umemura, T., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061805 · Cited by 12
Genetic deletion of miR-204 improves glycemic control despite obesity in db/db mice
Gaddam, R. R., Kim, Y., Li, Q., Jacobs, J. S., Gabani, M. H., Mishra, A., Promes, J. A., Imai, Y., Irani, K., & Vikram, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.077 · Cited by 12
Sachan, A., Singh, A., Shukla, S., Aggarwal, S., Mir, I. A., & Yadav, R. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20090 · Cited by 12
Dias, G. D. F., Cartolano, F. D. C., de Freitas, M. C. P., Helena, E. T. D. S., Markus, M. R. P., Santos, R. D., & Damasceno, N. R. T. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107856 · Cited by 12
El‐Saka, M. H., Barhoma, R. A., Ibrahim, R. R., Saadany, A. A. E., Alghazaly, G. M., Elshwaikh, S. L., Marea, K. E., & Madi, N. M. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22725 · Cited by 12
Tsiroukidou, K., Hatziagorou, E., Grammatikopoulou, M. G., Vamvakis, A., Kontouli, K., Tzimos, C., Tsanakas, J. N., & Spiliotis, B. E. (2021) · Nutrients · doi:10.3390/nu13020674 · Cited by 14
Ponirakis, G., Abdul‐Ghani, M. A., Jayyousi, A., Zirie, M. A., Al‐Mohannadi, S., Almuhannadi, H., Petropoulos, I. N., Khan, A., Gad, H., Migahid, O., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13582 · Cited by 11
Increased lipocalin 2 levels in adolescents with type 2 diabetes mellitus
Takaya, J., Tanabe, Y., & Kaneko, K. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0216 · Cited by 14
de Luis, D. A., Izaola, O., & Primo, D. (2021) · Disease Markers · doi:10.1155/2021/1257145 · Cited by 13
Sanctis, V. D., Soliman, A. T., Tzoulis, P., Daar, S., Maio, S. D., Fiscina, B., & KATTAMIS, C. A. (2021) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2021.051 · Cited by 15
Riseberg, E., James, K. A., Woodin, M., Melamed, R., Alderete, T. L., & Corlin, L. (2021) · Environmental Epidemiology · doi:10.1097/ee9.0000000000000173 · Cited by 13
Peng, W., Xie, Y., Xia, J., Li, B., Zhang, F., Wen, F., Liu, K., Cao, H., Qi, H., & Zhang, L. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10190-0 · Cited by 12
Wang, H., Wang, J., Zhu, Y., Yan, H., & Lu, Y. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182413141 · Cited by 15
Silva, S. D. S. E., Leite, N., Alle, L. F., de Souza, R. L. R., Corazza, P. R. P., Tadiotto, M. C., Milano, G. E., da Silva, L. R., Pizzi, J., Lopes, M. D. F. A., et al. (2022) · Gene · doi:10.1016/j.gene.2022.146296 · Cited by 12
Mahdavifard, S., & Nakhjavani, M. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01014-2 · Cited by 12
RetractedMetformin Alleviates Airway Hyperresponsiveness in a Mouse Model of Diet-Induced Obesity
Gu, C., Loube, J., Lee, R., Bevans‐Fonti, S., Wu, T. D., Barmine, J. H., Jun, J. C., McCormack, M. C., Hansel, N. N., Mitzner, W., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.883275 · Cited by 12
Early impaired β-cell function in chinese women with polycystic ovary syndrome.
Tao, T., Li, S., Zhao, A., Mao, X., & Liu, W. (2012) · Europe PMC (PubMed Central) · Cited by 12
Assessment of metabolic syndrome in patients with primary biliary cirrhosis
Alempijevic, T. M., Sokić-Milutinović, A., Marković, A. P., Ješić-Vukićević, R., Miličić, B., Μacut, D., Popović, D., & Tomić, D. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0162-9 · Cited by 12
NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY DISEASE FROM A BRAZIL NORTHEAST AREA
Vilar, C. P., Cotrim, H. P., Florentino, G. S. D. A., Bragagnoli, G., Schwingel, P. A., & Barreto, C. P. V. (2015) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032015000200007 · Cited by 12
Basal Glucagonlike Peptide 1 Levels and Metabolic Syndrome in Obese Patients
de Luis, D. A., Aller, R., Conde, R., Primo, D., Izaola, O., Castro, M. J., & Sagrado, M. G. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3182544f9e · Cited by 12
Psychosocial factors contribute to resting blood pressure in African Americans.
Pointer, M. A., Livingston, J. N., Yancey, S., McClelland, M. K., & Bukoski, R. D. (2008) · PubMed · Cited by 12
Low free testosterone in HIV ‐infected men is not associated with subclinical cardiovascular disease
Monroe, A. K., Dobs, A. S., Xu, X., Palella, F., Kingsley, L., Post, W. S., Witt, M., & Brown, T. T. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00988.x · Cited by 12
de Oliveira, A., Hermsdorff, H. H. M., Cocate, P. G., Bressan, J., Novello, A. A., dos Santos, E. C., & Natali, A. J. (2014) · PubMed · doi:10.3305/nh.2014.30.3.7540 · Cited by 12
Rutter, M. K., SULLIVAN, L. M., Fox, C. S., Wilson, P. W. F., Nathan, D. M., Vasan, R. S., D’Agostino, R. B., & Meigs, J. B. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0148 · Cited by 12
Gjevestad, E. S., Hjelmesaeth, J. S., Sandbu, R., & Nordstrand, N. (2014) · Obesity · doi:10.1002/oby.20880 · Cited by 13
Relationships between free leptin and insulin resistance in women with polycystic ovary syndrome.
Mohiti-Ardekani, J., Tarof, N., & D, A. A. M. (2009) · TSpace (University of Toronto) · Cited by 12
One day of overfeeding impairs nocturnal glucose but not fatty acid homeostasis in overweight men
Magkos, F., Smith, G. I., Reeds, D. N., Okunade, A. L., Patterson, B. W., & Mittendorfer, B. (2013) · Obesity · doi:10.1002/oby.20562 · Cited by 14
Argyri, K., Sotiropoulos, A., Psarou, E., Papazafiropoulou, A. K., Zampelas, A., & Kapsokefalou, M. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.39 · Cited by 12
Wallin, M. K. E. B., Selldén, E., Eksborg, S., & Brismar, K. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-2 · Cited by 12
Gamboa-Meléndez, M., Galindo-Gómez, C., Juárez-Martínez, L., Gómez, F., Díaz-Díaz, E., Ávila-Arcos, M., & Ávila-Curiel, A. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.07.008 · Cited by 14
Residual C-peptide secretion and endothelial function in patients with Type II diabetes
Manzella, D., Ragno, E., Abbatecola, A. M., et al. (2003) · Clinical Science · doi:10.1042/cs20020291 · Cited by 12
Tomiyama, H., Yambe, M., Yamada, J., Motobe, K., Koji, Y., Yoshida, M., Shiina, K., & Yamashina, A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280149518 · Cited by 12
Clément, K., Stunff, C. L., Meirhaeghe, A., Dechartres, A., Ferrières, J., Basdevant, A., Boîtard, C., Amouyel, P., & Bougneres, P. F. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.11.160 · Cited by 14
Tanaka, Y., Atsumi, Y., Matsuoka, K., Onuma, T., & Kawamori, R. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.710 · Cited by 12
Levels of Soluble CD40 Ligand and P-Selectin in Nonalcoholic Fatty Liver Disease
Erçin, C. N., Doğru, T., Tapan, S., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0817-1 · Cited by 12
.BETA.-cell Function is a Major Contributor to Oral Glucose Disposition in Obese Japanese Students
Asano, T., Yoshida, R., OGATA, H., Kokawa, K., OGIMOTO, M., Akehi, Y., Anzai, K., Ono, J., Tamura, K., HIDEHIRA, K., et al. (2007) · Endocrine Journal · doi:10.1507/endocrj.k07-016 · Cited by 12
Chen, I., Chao, T., Tsai, W., & Li, Y. (2010) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(10)60031-9 · Cited by 12
Conditioning causes an increase in glucose transporter-4 levels in mononuclear cells in sled dogs
Schnurr, T. M., Reynolds, A. J., Gustafson, S. J., Duffy, L. K., & Dunlap, K. L. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.09.009 · Cited by 12
Adiposity Gain During Childhood, ACE I/D Polymorphisms and Metabolic Outcomes
Ponsonby, A., Blizzard, L., Pezic, A., Cochrane, J., Ellis, J. A., Morley, R., Dickinson, J. L., Sale, M. M., Richards, S. M., & Dwyer, T. (2008) · Obesity · doi:10.1038/oby.2008.302 · Cited by 12
Zamami, Y., Fujiwara, H., 細田, 美., Hino, H., HIRAI, K., OKAMOTO, K., Jin, X. K., Takatori, S., Takai-Doi, S., & Kawasaki, H. (2010) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.130.833 · Cited by 12
Sadashiv, Tiwari, S., Paul, B. N., Kumar, S., Chandra, A., Dhananjai, S., & Negi, M. P. S. (2012) · Women s Health · doi:10.2217/whe.12.46 · Cited by 12
Torrens, J. M., Konieczna, J., Palou, M., Sánchez, J., Picó, C., & Palou, A. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.10.009 · Cited by 12
Ishizaka, N., Ishizaka, Y., Toda, E.-I., et al. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000264233 · Cited by 12
Bøg‐Hansen, E., Merlo, J., Gullberg, B., Melander, A., Råstam, L., & Lindblad, U. (2004) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430410006620 · Cited by 12
Ekici, B., & Cebeci, A. N. (2014) · Acta Neurologica Belgica · doi:10.1007/s13760-014-0340-9 · Cited by 12
Chen, G., Lai, X., Jiang, Q., Chen, F., Chen, N., Huang, H., Liang, J., Li, L., Wen, J., Lin, L., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.030 · Cited by 11
Normoglycemic Diabetic Nephropathy: The Role of Insulin Resistance
Filippone, E. J., Gupta, A., & Farber, J. L. (2014) · Case Reports in Nephrology and Dialysis · doi:10.1159/000364901 · Cited by 12
Anan, F., Masaki, T., Takeshi, E. T. O., Fukunaga, N., Iwao, T., Kaneda, K., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.1565 · Cited by 12
Lam, P. M., Tam, W. H., Ronald, C. W., Cheung, L. P., Tsui, M. H. Y., Tong, P. C. Y., Chow, F. C. C., Lam, C. W. K., Chan, M. H. M., Chan, J. C. N., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.085 · Cited by 12
An unexpectedly high prevalence of undiagnosed diabetes in patients awaiting lung transplantation
Hackman, K. L., Snell, G. I., & Bach, L. A. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.10.010 · Cited by 12
Kumagai, S., Kai, Y., Nagano, M., Zou, B., Kishimoto, H., & Sasaki, H. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.213 · Cited by 12
Carotid intima-media thickness in patients with liver cirrhosis associated with diabetes mellitus
Tamura, M., Kihara, Y., & Otsuki, M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.03.013 · Cited by 12
The genetics and pathophysiology of diabetes mellitus type II
Jenkins, A. B., & Campbell, L. V. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000031097.31587.81 · Cited by 12
Blüher, S., Raschpichler, M., Hirsch, W., & Till, H. (2012) · Metabolism · doi:10.1016/j.metabol.2012.11.001 · Cited by 12
Borai, A., Livingstone, C., Heald, A. H., et al. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213495818 · Cited by 12
Assessment of Physical and Mental Health in Male University Students with Varying Sleep Habits
Matsumoto, Y., Toyomasu, K., & Uchimura, N. (2011) · The Kurume Medical Journal · doi:10.2739/kurumemedj.58.105 · Cited by 12
Fukuda, K., Seki, Y., Ichihi, M., Okada, T., Hirata, A., Kogita, S., Sawai, Y., Igura, T., Tsugawa, M., & Imai, Y. (2015) · Journal of Medical Ultrasonics · doi:10.1007/s10396-015-0615-7 · Cited by 12
Papandreou, D., Rousso, I., Economou, I., et al. (2008) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637480701780088 · Cited by 12
Yoo, D. E., Lee, M. J., Oh, H. J., et al. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0032 · Cited by 12
Association of ADIPOR2 With Liver Function Tests in Type 2 Diabetic Subjects
López‐Bermejo, A., Botas-Cervero, P., Ortega, F. J., Delgado, E., García-Gil, M., Funahashi, T., Ricart, W., & Fernández‐Real, J. M. (2008) · Obesity · doi:10.1038/oby.2008.344 · Cited by 12
Çetinkalp, Ş., Karadeniz, M., Erdoğan, M., Özgen, G., Saygl, F., & Ylmaz, C. (2009) · The Endocrinologist · doi:10.1097/ten.0b013e3181a58772 · Cited by 12
Needham, B. L., KIM, C., Mukherjee, B., Bagchi, P., Stanczyk, F. Z., & Kanaya, A. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12642 · Cited by 12
ADELUIS, D., Aller, R., Izaola, O., Sagrado, M. G., & Conde, R. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.09.009 · Cited by 12
Kabat, G. C., Heo, M., Horn, L. V., Kazlauskaite, R., Getaneh, A., Ard, J. D., Vitolins, M. Z., Waring, M. E., Zaslavsky, O., Wassertheil-Smoller, S. W., et al. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.10.007 · Cited by 12
Rufino, M., Hernández, D., Barrios, Y., et al. (2008) · Nephron Clinical Practice · doi:10.1159/000118940 · Cited by 12
Gu, N., Ma, X., Zhang, J., Dong, A., Jin, M., Feng, N., Zhang, H., & Guo, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109805 · Cited by 12
The effects of pioglitazone on cerebrovascular resistance in patients with type 2 diabetes mellitus
Park, J. S., Cho, M. H., Lee, K., Kim, C. S., Kim, H. J., Nam, J. S., Ahn, C. W., Soo, B., Lim, S. K., Kim, K. R., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2007.03.017 · Cited by 12
Alissa, E. M., Alnahdi, W. A., Alama, N., & Ferns, G. A. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.09.001 · Cited by 12
Intramyocellular lipid variations in active older men: relationship with aerobic fitness
Rouffet, D., Villars, C., Fissoune, R., Sappey‐Marinier, D., Laville, M., Ibarrola, D., Sothier, M., Monnet, M.-F., Ovize, M., Bonnefoy, M., et al. (2012) · Acta Physiologica · doi:10.1111/apha.12045 · Cited by 12
Walsh, J., Wallace, M., Brennan, L., & McAuliffe, F. M. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.966672 · Cited by 12
Surrogate estimates of insulin sensitivity in Chinese diabetic patients and their offspring
Kuo, C., Hwu, C., Kwok, C. F., Hsiao, L., Weih, M. J., Lee, S. H., Lee, Y. S., & Ho, L. T. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00668.x · Cited by 12
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
